Patented technology that enables, for topicals, sustained release, increased druggability, a Patchless Patch concept, and enhanced targeting of pores and follicles
Location: United States, South Carolina, Greenville
Employees: 11-50
Founded date: 2017
Investors 6
| Date | Name | Website |
| - | Chemical A... | chemicalan... |
| 17.05.2025 | Cowtown An... | cowtownang... |
| - | Arcview Co... | arcviewven... |
| - | Ariel Sava... | asap-inves... |
| - | New York A... | newyorkang... |
| - | Endless Fr... | endlessfro... |
Mentions in press and media 10
| Date | Title | Description |
| 21.08.2025 | XXIV Launches New twentyfour skincare Brand Featuring Two Patented Technologies | A new player enters the beauty industry. We are thrilled to introduce twentyfour skincare. This launch underscores our focus on sustained-release skincare built on scientific research.” — Jenny Pancoast GREENVILLE, SC, UNITED STATES, August... |
| 14.04.2025 | Atticus Pharma (Life Sciences, '23-24) Announces Initiation of the First Human Clinical Trial of ATC-002 | - |
| 13.11.2024 | Zylö’s ‘Powered by Z-pod’ technology named twice as a finalist in the prestigious C&T Allē Awards | GREENVILLE, SC, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Zylö’s patented Z-pod® topical delivery platform was recently named as a 2025 Cosmetic & Toiletries (C&T) Allē Awards finalist in two categories: (i) Anti-Aging Ingredient Blend and ... |
| 16.09.2022 | Zylö Receives $263,000 NIH Phase I Grant to Develop a Topical Viagra® for ED | Funds to be used to optimize a formulation and demonstrate comparable efficacy to oral Viagra GREENVILLE, SC, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., developer of the Z-pod® topical delivery platform, has been awarded a o... |
| 03.06.2022 | Zylö Therapeutics Closes $5.225 Million Series B Financing | GREENVILLE, SC, June 03, 2022 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., dedicated to developing a transformational drug-delivery platform, announced that it has raised $5.225 million in its Series B financing. The Series B round was led b... |
| 10.11.2021 | Zylö’s Erectile Dysfunction Product Concept Wins Best Abstract Award | The product concept uses patent-pending Z-pods™ to sustainably—for over an hour—release nitric oxide GREENVILLE, SC, Nov. 10, 2021 (GLOBE NEWSWIRE) -- A novel nitric-oxide-releasing product concept developed by Zylö Therapeutics was awarded... |
| 20.07.2021 | Zylö Receives $1,700,000 NIH Phase II Grant to Advance Erectile Dysfunction Program into Human Trials | Funds to be used for scale-up, implementation of cGMP quality system, and pre-IND FDA meeting GREENVILLE, SC, July 20, 2021 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., developer of the transformational Z-pod™ topical delivery platform, has ... |
| 19.05.2021 | Zylö and Amifar Laboratorios Forge Broad-Ranging Partnership | The Z-pod™ delivery system will further enhance the ‘Science of Beauty’ GREENVILLE, SC, May 19, 2021 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., developer of the transformational Z-pod™ topical delivery platform, announced that it has enter... |
| 29.04.2021 | Charles E. Hinkle Joins Zylö as Chief Financial Officer | GREENVILLE, SC, April 29, 2021 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., developer of the transformational Z-pod™ topical delivery platform, announced that Charles E. Hinkle joined its executive team as chief financial officer during the ... |
| 26.09.2019 | Zylö Therapeutics Raises $4M in Series A Financing | Zylö Therapeutics Inc., a Greenville, SC-based company developing a topical delivery platform, closed its $4m Series A financing. Approximately $1.35m of this total was invested prior to this year and was converted into Series A shares as p... |